CD44-negative parietal-epithelial cell staining in minimal change disease: association with clinical features, response to corticosteroids and kidney outcome

MLA

Anabel Abo, et al. CD44-Negative Parietal-Epithelial Cell Staining in Minimal Change Disease: Association with Clinical Features, Response to Corticosteroids and Kidney Outcome. Jan. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3e9a194c62c990d8b6899a419c8d7915&authtype=sso&custid=ns315887.

APA

Anabel Abo, Alejandro Cruz, Alfons Segarra, Cristina Martínez, Jorge González, Álvaro Madrid, Gloria Fraga, Maria Santacana, Marisa Martin, Neus Roca, Elias Jatem, & Anna Balius. (2022). CD44-negative parietal-epithelial cell staining in minimal change disease: association with clinical features, response to corticosteroids and kidney outcome.

Chicago

Anabel Abo, Alejandro Cruz, Alfons Segarra, Cristina Martínez, Jorge González, Álvaro Madrid, Gloria Fraga, et al. 2022. “CD44-Negative Parietal-Epithelial Cell Staining in Minimal Change Disease: Association with Clinical Features, Response to Corticosteroids and Kidney Outcome,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3e9a194c62c990d8b6899a419c8d7915&authtype=sso&custid=ns315887.